REPOCEUTICALS A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About REPOCEUTICALS A/S
REPOCEUTICALS A/S (CVR number: 36494433K) is a company from HØRSHOLM. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -5468.9 kDKK, while net earnings were -5199.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -57 %, which can be considered poor and Return on Equity (ROE) was -93.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 29.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. REPOCEUTICALS A/S's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | |||||
EBIT | - 558.48 | -1 200.51 | -5 458.62 | -4 974.66 | -5 468.94 |
Net earnings | - 523.22 | - 858.80 | -4 402.35 | -3 828.78 | -5 199.74 |
Shareholders equity total | 6 041.72 | 5 182.91 | 12 040.52 | 8 300.36 | 2 838.44 |
Balance sheet total (assets) | 8 154.08 | 9 885.45 | 14 335.06 | 9 490.66 | 9 686.12 |
Net debt | - 316.52 | - 132.34 | -5 601.22 | -1 207.45 | -1 152.08 |
Profitability | |||||
EBIT-% | |||||
ROA | -8.2 % | -13.3 % | -45.1 % | -41.8 % | -57.0 % |
ROE | -9.4 % | -15.3 % | -51.1 % | -37.6 % | -93.4 % |
ROI | -24.4 % | -28.7 % | -71.5 % | -49.6 % | -65.0 % |
Economic value added (EVA) | - 252.18 | - 455.57 | -3 701.29 | -3 829.26 | -4 976.69 |
Solvency | |||||
Equity ratio | 89.1 % | 61.7 % | 87.8 % | 87.5 % | 29.3 % |
Gearing | |||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.5 | 0.3 | 4.4 | 2.2 | 1.9 |
Current ratio | 1.6 | 0.3 | 4.4 | 2.2 | 1.9 |
Cash and cash equivalents | 316.52 | 132.34 | 5 601.22 | 1 207.45 | 1 152.08 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.